Within the last decade, research regarding the human gut microbiome has exploded. While the gastrointestinal tract was once regarded simply as a digestive organ, new technologies have led the science world to wonder about the impact that the gut microbiota may have on human health and disease. The gut microbiome is now becoming known for its role in metabolism, immune defense, and behavior. From in utero variations to those that rapidly occur post partum, our gut microbiome changes with age, environment, stress, diet, and health status as well as medication exposure. This article reviews what is currently known regarding various influences on the gut microbiome and is meant to encourage the reader to further explore the unknown.
LewisK. Platforms for antibiotic discovery. Nat Rev. 2013;12:371-387.
2.
Human Microbiome Project Consortium. A framework for human microbiome research. Nature. 2012;486:215-221.
3.
Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;86:207-214.
4.
BackhedFLeyRESonnenburgJLPetersonDAGordonJI. Host-bacterial mutualism in the human intestine. Nature. 2005;307:1915-1920.
5.
DingTSchlossPD. Dynamics and associations of microbial community types across the human body. Nature. 2014;509(7500):357-360.
6.
SalazarNArboleyaSValdésL. The human intestinal microbiome at extreme ages of life. Front Genet. 2014;5:1-9.
7.
DiGiulioDB. Diversity of microbes in amniotic fluid. Semin Fetal Neonatal Med. 2012;17:2-11.
8.
JiménezEFernándesLMarínM. Isolation of commensal bacteria from umbilical cord blood of healthy neonates born by cesarean section. Curr Microbiol. 2005;51:270-274.
9.
AagardKMaJAntonyK. The placenta harbors a unique microbiome. Sci Transl Med. 2014;6:237-265.
10.
MolesLGomezMHeiligH. Bacterial diversity in meconium of preterm neonates and evolution of their fecal microbiota during the first months of life. PLoS One. 2013;8:1-13.
11.
JimenezEMarínMLMartínR. Is meconium from healthy newborns actually sterile?Res Microbiol. 2008;159:187-193.
12.
AlfalehKAnabreesJ. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev. 2014;(4):CD005496.
13.
Athalye-JapeGDeshpandeGRaoSPatoleS. Benefits of probiotics on enteral nutrition in preterm neonates: a systematic review. Am J Clin Nutr. 2014;100:1508-1519.
14.
ClementeJCUrsellLKParfreyLW. The impact of the gut microbiota on human health: an integrated view. Cell. 2012;148:1258-1270.
15.
JakobssonHEAbrahamssonTRJenmalmMC. Decreased gut microbiota diversity, delayed Bacteriodetes colonisation and reduced Th1 responses in infants delivered by caesarean section. Gut. 2014;63:559-566.
16.
KoenigJESporAScalfoneN. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A. 2011;108(suppl 1):4578-4585.
17.
PopM. We are what we eat: how the diet of infants affects their gut microbiome. Genome Biol. 2012;13:152.
18.
PalmerCBikEMDiGiulioDBRelmanDABrownPO. Development of the human infant intestinal microbiota. PLoS Biol. 2007;5:e177.
19.
MorowitzMJDenefVJCostelloEK. Strain-resolved community genomic analysis of gut microbial colonization in a premature infant. Proc Natl Acad Sci U S A. 2011;108:1128-1133.
20.
SchwartzSFriedbergIIvanovI. A metagenomic study of diet-dependent interaction between gut microbiota and host in infants reveals differences in immune response. Genome Biol. 2012;13:r32.
21.
Le Huerou-LuronIBlatSBoudryGBreast- v. formula-feeding: impacts on the digestive tract and immediate and long-term health effects. Nutr Res Rev. 2010;23:23-36.
22.
MartínRJiménezEHeiligH. Isolation of Bifidobacteria from breast milk and assessment of the bifidobacterial population by PCR-denaturing gradient gel electrophoresis and quantitative real-time PCR. Appl Environ Microbiol. 2009;75:965-969.
23.
GermanJBFreemanSLLebrillaCBMillsDA. Human milk oligosaccharides: evolution, structures and bioselectivity as substrates for intestinal bacteria. Nestle Nutr Workshop Ser Pediatr Program. 2008;62:205-222.
24.
BalmerSEWhartonBA. Diet and faecal flora in the newborn: breast milk and infant formula. Arch Dis Child. 1989;64:1672-1677.
25.
FukudaSTohHHaseK. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature. 2011;469:543-547.
26.
OuwehandAIsolauriESalminenS. The role of the intestinal microflora for the development of the immune system in early childhood. Eur J Nutr. 2002;41(suppl 1):I32-I37.
27.
StarkPLLeeA. The microbial ecology of the large bowel of breast-fed and formula-fed infants during the first year of life. J Med Microbiol. 1982;15:189-203.
28.
HarmsenHKWildeboer-VelooACRaangsGC. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr. 2000;30:61-67.
29.
StarkPLLeeAParsonageBD. Colonization of the large bowel by Clostridium difficile in healthy infants: quantitative study. Infect Immun. 1982;35:895-899.
30.
MarcobalABarbozaMSonnenburgED. Bacteroides in the infant gut consume milk oligosaccharides via mucus-utilization pathways. Cell Host Microbe. 2011;10:507-514.
31.
Beereman-WautersGStaelensSVan de BroekH. Physiological and bifidogenic effects of prebiotic supplements in infant formulae. J Pediatr Gastroenterol Nutr. 2011;52:763-771.
32.
KoenigJESporAScalfoneN. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A. 2011;108(suppl 1):4578-4585.
33.
SalazarNArboleyaSValdésL. The human intestinal microbiome at extreme ages of life. Front Genet. 2014;5:1-9.
34.
ClaessonMJCusackSO’SullivanO. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A. 2011;108(suppl 1):4586-4591.
35.
OttmanNSmidtHde VosWMBelzerC. The function of our microbiota: who is out there and what do they do?Front Cell Infect Microbiol. 2012;2:104.
36.
LovatLG. Age related changes in gut physiology and nutritional status. Gut. 1996;38:306-309.
37.
ZwielehnerJLisztKHandschurMLasslCLapinAHaslbergerAG. Combined PCR-DGGE fingerprinting and quantitative PCR indicates shifts in fecal population sizes and diversity of Bacteroides, Bifidobacteria and Clostridium cluster IV in institutionalized elderly. Exp Gerontol. 2009;44:440-446.
38.
Van TongerenSPSlaetsJPJHarmsenHKMWellingGW. Fecal microbiota composition and frailty. Appl Environ Microbiol. 2005;71:6438-6442.
39.
ClaessonMJJefferyIBCondeS. Gut microbiota composition correlates with diet and health in the elderly. Nature. 2012;488:178-184.
40.
PrideauxLKangSWagnerJ. Impact of ethnicity, geography, and disease on the microbiota in health and inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:2906-2918.
41.
YatsunenkoTReyFEManaryMJ. Human gut microbiome viewed across age and geography. Nature. 2012;486:222-227.
42.
MeakinsTSJacksonAA. Salvage of exogenous urea nitrogen enhances nitrogen balance in normal men consuming marginally inadequate protein diets. Clin Sci (Lond). 1996;90:215-212.
43.
MueggeBDKuczynskiJKnightsD. Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science. 2011;332:970-974.
44.
ArumugamMRaesJPelletierE. Enterotypes of the human gut microbiome. Nature. 2011;473:174-180.
45.
WoodmanseyEJ. Intestinal bacteria and ageing. J Appl Microbiol. 2007;102:1178-1186.
46.
TurnbaughPJLeyREMahowaldMAMagriniVMardisERGordonJI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027-1031.
47.
De FilippoCCavalieriDDi PaolaM. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A. 2010;107:14691-14696.
48.
QinJLiRRaesJ. MetaHIT Consortium. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464:59-65.
49.
FlintHJBayerEARinconMTLamedRWhiteBA. Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nat Rev Microbiol. 2008;6:121-131.
50.
ZimmerJLangeBFrickJS. A vegan or vegetarian diet substantially alters the human colonic faecal microbiota. Eur J Clin Nutr. 2012;66:53-60.
51.
LucassenPJPruessnerJSousaN. Neuropathology of stress. Acta Neuropathol. 2014;127:109-135.
52.
De PalmaGCollinsSMBercikPVerduEF. The microbiota-gut-brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both?J Physiol. 2014;14:2989-2997.
53.
LyteMVulchanovaLBrownDR. Stress at the intestinal surface: catecholamines and mucosa-bacteria interactions. Cell Tissue Res. 2011;343:23-32.
54.
LyteM. Probiotics function mechanistically as delivery vehicles for neuroactive compounds: microbial endocrinology in the design and use of probiotics. Bioessays. 2011;33:574-581.
55.
de OliveiraEPBuriniRCJeukendrupA. Gastrointestinal complaints during exercise: prevalence, etiology, and nutritional recommendations. Sports Med. 2014;44(suppl 1):S79-S85.
56.
ClarkeSFMurphyEFO’SullivanO. Exercise and associated dietary extremes impact on gut microbial diversity. Gut. 2014;64:1913-1920.
57.
O’SullivanOCorninWClarkeSF. Exercise and the microbiota. Gut Microb. 2015;6(2):131-136.
58.
BalducciSZanusoSNicolucciA. Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss. Nutr Metab Cardiovasc Dis. 2010;20:608-617.
59.
Lara FernandesJSerranoCVToledoF. Acute and chronic effects of exercise on inflammatory markers and B type natriuretic peptide in patients with coronary artery disease. Clin Res Cardiol. 2011;100:77-84.
60.
TisiPVHulseMChulakadabbaAGoslingPShearmanCP. Exercise training for intermittent claudication: does it adversely affect biochemical markers of exercise-induced inflammatory response?Eur J Vasc Endovasc Surg. 1997;14:344-350.
61.
HoSSDhaliwalSSHillsAPPalS. Effects of chronic exercise training on inflammatory markers in Australian overweight and obese individuals in a randomized controlled trial. Inflammation. 2013;36:625-632.
62.
Hoffman-GoetzLSpangnuoloPAGuanJ. Repeated exercise in mice alters expression of IL-10 and TNF-alpha in intestinal lymphocytes. Brain Behav Immun. 2008;22:195-199.
63.
Hoffman-GoetzLPervaizNPackerNGuanJ. Free-wheel training decreases pro-and increases anti-inflammatory cytokine expression in mouse intestinal lymphocytes. Brain Behav Immun. 2010;24:1105-1115.
64.
KasimayOGuzelEGemiciA. Colitis-induced oxidative damage of the colon and skeletal muscle is ameliorated by regular exercise in rats: the anxiolytic role of exercise. Exp Physiol. 2006;91:897-906.
65.
OktedalenOLundeOCOpstadPKAabakkenLKverneboK. Changes in the gastrointestinal mucosa after long-distance running. Scand J Gastroenterol. 1992;27(4):270-274.
66.
PalsKLChangRTRyanAJGisolfiCV. Effect of running intensity on intestinal permeability. J Appl Physiol. 1997;82(2):571-576.
67.
Brock-UtneJGGaffinSLWellsMT. Endotoxaemia in exhausted runners after a long-distance race. S Afr Med J. 1988;73:533-536.
68.
TiollierEChennaouiMGomez-MerinoDDrogouCFilaireEGuezennecCY. Effect of a probiotics supplementation on respiratory infections and immune and hormonal parameters during intense military training. Mil Med. 2007;172:1006-1011.
69.
GleesonM. Intense exercise training and immune function. Nestle Nutr Inst Workshop Series. 2013;76:39-50.
70.
GleesonMBishopNOliveiraMMcCauleyTTaulerPLawrenceC. Effects of a Lactobacillus salivarius probiotic intervention on infection, cold symptom duration and severity, and mucosal immunity in endurance athletes. Int J Sports Nutr Exerc Metab. 2012;22:235-242.
71.
HaywoodBBlackKBakerDMcGarveyJHealeyPBrownR. Probiotic supplementation reduces the duration and incidence of infections but not severity in elite rugby union players. J Sci Med Sports. 2014;17:356-360.
72.
CoxAJPyneDBSaundersPUFrickerPA. Oral administration of the probiotic Lactobacillus fermentum VRI-003 and mucosal immunity in endurance athletes. Br J Sports Med. 2010;44:222-226.
73.
WestNPyneDCrippsAHopkinsWEskesenDJairathA. Lactobacillus fermentum (PCC®) supplementation and gastrointestinal and respiratory tract illness symptoms: a randomized control trial in athletes. Nutr J. 2011;10:30.
74.
WestNHornPPyneDGebskiVLahtinenSFrickerPCrippsA. Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals. Clin Nutr. 2014;33:581-587.
75.
KekkonenRAVasankariTJVuorimaaTHaahtelaTJulkunenIKorpelaR. The effect of probiotics on respiratory infections and gastrointestinal symptoms during training in marathon runners. Int J Sports Nutr Exerc Metab. 2007;17:352-363.
76.
MartarelliDVerdenelliMCScuriS. Effect of a probiotic intake on oxidant and antioxidant parameters in plasma of athletes during intense exercise training. Curr Microbiol. 2011;62:1689-1696.
77.
MittalRCoopersmithCM. Redefining the gut as the motor of critical illness. Trends Mol Med. 2014;20:214-223.
78.
ShimizuKOguraHGotoM. Altered gut flora and environment in patients with severe SIRS. J Trauma. 2006;60:126-133.
79.
ShimizuKOguraHHamasakiT. Altered gut flora are associated with septic complications and death in critically ill patients with systemic inflammatory response syndrome. Dig Dis Sci. 2010;56:1171-1177.
80.
OsukaAShimizuKOguraH. Prognostic impact of fecal pH in critically ill patients. Crit Care. 2012;16:R119.
81.
HayakawaMAsaharaTHenzanN. Dramatic changes of the gut flora immediately after severe and sudden insults. Dig Dis Sci. 2011;56:2361-2365.
82.
SiemposIINtaidouTKFalagasME. Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. Crit Care Med. 2010;38:954-962.
83.
JainPMcNaughtCEAndersonADGMacFieJMitchellCJ. Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilis, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomized controlled trial. Clin Nutr. 2004;23:467-475.
84.
KlarinBJohanssonMLMolinGLarssonAJeppssonB. Adhesion of the probiotic bacterium Lactobacillus plantarum 299v onto the gut mucosa in critically ill patients: a randomised open trial. Crit Care. 2005;9:R285-R293.
85.
KotzampassiKGiamarellos-BourboulisEJVoudourisAKazamiasPEleftheriadisE. Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically ill trauma patients: early results of a randomized controlled trial. World J Surg. 2006;30:1848-1855.
86.
McNaughtCWoodcockNPAndersonADGMacFieJ. A prospective randomized trial of probiotics in critically ill patients. Clin Nutr. 2005;24:211-219.
87.
BesselinkMGvan SantvoortHCBuskensE. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;371(9613):651-659.
88.
Spindler-VeselABengmarkSVovkICerovicOKompanL. Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients. JPEN J Parenter Enteral Nutr. 2007;31:119-126.
89.
GuWJWeiCYYinRX. Lack of efficacy of probiotics in preventing ventilator-associated pneumonia: a systematic review and meta-analysis of randomized controlled trials. Chest. 2012;142(4):859-868.
90.
PetrofEODhaliwalRManzanaresWJohnstoneJCookDHeylandDK. Probiotics in the critically ill: a systematic review of the randomized trial evidence. Crit Care Med. 2012;40:3290-3302.
91.
WatkinsonPJBarberVSDarkP. The use of pre- pro-and synbiotics in adult intensive care unit patients: systematic review. Clin Nutr. 2007;26:182-192.
92.
TrackNS. The gastrointestinal endocrine system. Can Med Assoc J. 1980;122:287-292.
93.
HeitkemperMMCainKCBurrRLJunSEJarrettME. Is childhood abuse or neglect associated with symptom reports and physiological measures in women with irritable bowel syndrome?Biol Res Nurs. 2011;13:399-408.
94.
WuJC. Psychological co-morbidity in functional gastrointestinal disorders: epidemiology, mechanisms, and management. J Neurogastroenterol Motil. 2012;18:13-18.
95.
Van TilburgMAPalssonOSWhiteheadWE. Which psychological factors exacerbate irritable bowel syndrome? Development of a comprehensive model. J Psychosom Res. 2013;74:486-492.
96.
LaddCOHuotRLThrivikramanKVNemeroffCBMeaneyMJPlotskyPM. Long-term behavioral and neuroendocrine adaptations to adverse early experience. Prog Brain Res. 2000;122: 81-103.
97.
BarreauFFerrierLFioramontiJBuenoL. Neonatal maternal deprivation triggers long term alterations in colonic epithelial barrier and mucosal immunity in rats. Gut. 2004;53:501-506.
98.
DanielsWMPietersenCYCarstensMESteinDJ. Maternal separation in rats leads to anxiety-like behavior and a blunted ACTH response and altered neurotransmitter levels in response to a subsequent stressor. Metab Brain Dis. 2004;19:3-14.
99.
LippmannMBressANemeroffCBPlotskyPMMonteggiaLM. Long-term behavioral and molecular alterations associated with maternal separation in rats. Eur J Neurosci. 2007;25:3091-3098.
100.
AisaBTorderaRLasherasBDel RíoJRamírezMJ. Effects of maternal separation on hypothalamic-pituitary-adrenal responses, cognition and vulnerability to stress in adult female rats. Neuroscience. 2008;154:1218-1226.
OinesEMurisonRMrdaljJGrønliJMildeAM. Neonatal maternal separation in male rats increases intestinal permeability and affects behavior after chronic social stress. Physiol Behav. 2012;105:1058-1066.
103.
VargheseAKVerduEFBercikP. Antidepressants attenuate increased susceptibility to colitis in a murine model of depression. Gastroenterology. 2006;130:1743-1753.
104.
DesbonnetLGarrettLClarkeGKielyBCryanJFDinanTG. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience. 2010;170:1179-1188.
105.
O’MahonySMHylandNPDinanTGCryanJF. Maternal separation as a model of brain-gut axis dysfunction. Psychopharmacology (Berl). 2011;214:71-88.
106.
LiMXueXShaoSShaoFWangW. Cognitive, emotional and neurochemical effects of repeated maternal separation in adolescent rats. Brain Res. 2013;1518:82-90.
107.
EutameneHLamineFChaboC. Synergy between Lactobacillus paracasei and its bacterial products to counteract stress-induced gut permeability and sensitivity increase in rats. J Nutr. 2007;137:1901-1907.
108.
FeliceVDGibneySMGosselinRDDinanTGO’MahonySMCryanJF. Differential activation of the prefrontal cortex following psychological stress and colorectal distension in the maternally separated rat. Neuroscience. 2014;267:252-262.
109.
MoloneyRDO’LearyOFFeliceDBettlerBDinanTGCryanJF. Early-life stress induces visceral hypersensitivity in mice. Neurosci Lett. 2012;512:99-102.
110.
O’MalleyDJulio-PieperMGibneySMDinanTGCryanJF. Distinct alterations in colonic morphology and physiology in two rat models of enhanced stress-induced anxiety and depression-like behavior. Stress. 2010;13:114-122.
111.
GareauMGJuryJMacQueenGShermanPMPerdueMH. Probiotic treatment of rat pups normalizes corticosterone release and ameliorates colonic dysfunction induced by maternal separation. Gut. 2010;56:1522-1528.
112.
SoderholmJDYatesDAGareauMGYangPCMacqueenGPerdueMH. Neonatal maternal separation predisposes adult rats to colonic barrier dysfunction in response to mild stress. Am J Physiol Gastrointest Liver Physiol. 2002;283:G1257-G1263.
113.
BarreauFCartierCFerrierLFioramontiJBuenoL. Nerve growth factor mediates alterations of colonic sensitivity and mucosal barrier induced by neonatal stress in rats. Gastroenterology. 2004;127:524-534.
114.
GareauMGJuryJPerdueMH. Neonatal maternal separation of rat pups results in abnormal cholinergic regulation of epithelial permeability. Am J Physiol Gastrointest Liver Physiol. 2007;293:G198-G203.
115.
OinesEMurisonRMrdaljJGrønliJMildeAM. Neonatal maternal separation in male rats increases intestinal permeability and affects behavior after chronic social stress. Physiol Behav. 2012;105:1058-1066.
116.
BarreauFFerrierLFioramontiJBuenoL. New insights in the etiology and pathophysiology of irritable bowel syndrome: contribution of neonatal stress models. Pediatr Res. 2007;62:240-245.
117.
O’MahonySMMarchesiJRScullyP. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry. 2009;65:263-267.
118.
BaroueiJMoussaviMHodgsonDM. Effect of maternal probiotic intervention on HPA axis, immunity and gut microbiota in a rat model of irritable bowel syndrome. PLoS One. 2012;7:e46051.
119.
García-RodenasCLBergonzelliGENuttenS. Nutritional approach to restore impaired intestinal barrier function and growth after neonatal stress in rats. J Pediatr Gastroenterol Nutr. 2006;43:16-24.
120.
EutameneHBuenoL. Role of probiotics in correcting abnormalities of colonic flora induced by stress. Gut. 2007;56:1495-1497.
121.
DistruttiECiprianiSMencarelliARengaBFiorucciS. Probiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndrome. PLoS One. 2013;8:e63893.
122.
HsiaoEYMcBrideSWHsienS. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 2013;155:1451-1463.
123.
BarrettERossRPO’ToolePWFitzgeraldGFStantonC. γ-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol. 2012;113:411-417.
124.
BarrettEFitzgeraldPDinanTG. Bifidobacterium breve with α-linolenic acid and linoleic acid alters fatty acid metabolism in the maternal separation model of irritable bowel syndrome. PLoS One. 2012;7:e48159.
125.
BercikPParkAJSinclairD. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil. 2011;23:1132-1139.
126.
BravoJADinanTGCryanJF. Alterations in the central CRF system of two different rat models of comorbid depression and functional gastrointestinal disorders. Int J Neuropsychopharmacol. 2011;14:666-683.
127.
BercikPDenouECollinsJ. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology. 2011;141:599-609, 609e.1-3.
128.
BercikPVerduEFFosterJA. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology. 2010;139:2102-2112.
129.
CarmodyRNTurnbaughPJ. Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics. J Clin Invest. 2014;124:4173-4181.
130.
SousaTPatersonRMooreVCarlssonAAbrahamssonBBasitAW. The gastrointestinal microbiota as a site for the biotransformation of drugs. Int J Pharm. 2008;363:1-25.
131.
PeppercornMAGoldmanP. The role of intestinal bacteria in the metabolism of salicylazosulfapyridine. J Pharm Exp Ther. 1972;181:555-562.
132.
LaparraJMSanzY. Interactions of gut microbiota with functional food components and nutraceuticals. Pharmacol Res. 2010;61:219-225.
133.
StecherBHardtWD. Mechanisms controlling pathogen colonization of the gut. Curr Opin Microbiol. 2011;14:82-91.
134.
RataupliSKEllingtonTGO’NeillMT. Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth. Am J Gastroenterol. 2012;107:730-735.
135.
AlhazzaniWAleneziFJaeschkeRZMoayyediPCookDJ. 2. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis. Crit Care Med. 2013;41:693-705.
136.
SanduleanuSJonkersDDe BruineAHameetemanWStockbruggerRW. Non-Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa. Aliment Pharmacol Ther. 2001;15:379-388.
137.
LombardoLFotiMRuggiaOChiecchioA. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin Gastroenterol Hepatol. 2010;8:504-508.
138.
PilottoAFranceschiMVitaleD. The prevalence of diarrhea and its association with drug use in elderly outpatients: a multicenter study. Am J Gastroenterol. 2008;103:2816-2823.
139.
TheisenJNehraDCitronD. Suppression of gastric acid secretion in patients with GERD results in gastric bacterial overgrowth and deconjugation of bile acids. J Gastrointest Surg. 2000;4:50-54.
140.
LombardoL. PPI use and SIBO: predisposition or cause?Am J Gastroenterol. 2012;107:1923.
141.
JernbergCLofmarkSEdlundCJanssonJK. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J. 2007;1:56-66.
142.
LofmarkSJernbergCJanssonJKEdlundC. Clindamycin-induced enrichment and long-term persistence of resistant Bacteroides spp. and resistance genes. J Antimicrob Chemother. 2006;58:1160-1167.
143.
BelenguerADuncanSHCalderAG. Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl Environ Microbiol. 2006;72:3593-3599.
144.
SmithDLHarrisADJohnsonJASilbergeldEKMorrisJGJr.Animal antibiotic use has an early but important impact on the emergence of antibiotic resistance in human commensal bacteria. Proc Natl Acad Sci U S A. 2002;99:6434-6439.
145.
WillingBPRussellSLFinlayBB. Shifting the balance: antibiotic effects on host-microbiota mutualism. Nat Rev. 2011;9:233-243.
146.
AtarashiK. Induction of colonic regulatory T cells by indigenous Clostridium species. Science. 2011;331:337-341.
147.
ToppingDLCliftonPM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev. 2001;81:1031-1064.
WlodarskaMWillingBKeeneyKM. Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis. Infect Immun. 2011;79:1536-1545.
150.
TheriotCMKoenigsknechtMJCarlsonPE. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nature Comm. 2014;5:3114.
151.
HamiltonMJWeingardenARSadowskyMJ. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012;107:761-767.
152.
ChangJYAntonopoulosDAKalraA. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea.J Infect Dis. 2008;197:435-438.
153.
BrandtLJAroniadisOCMellowM. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012;107:1079-1087.
154.
WageZKYangYSChenYe. Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease. World J Gastroenterol. 2014;20:14805-14820.
155.
OuwehandAIsolauriESalminen. The role of the intestinal microflora for the development of the immune system in early childhood. Eur J Nutr. 2002;41(suppl 1):I32-I37.
156.
YoungVBSchmidtTM. Overview of the gastrointestinal microbiota. Adv Exp Med Biol. 2008;635:29-40.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
